433 related articles for article (PubMed ID: 32879731)
1. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19).
Danwang C; Endomba FT; Nkeck JR; Wouna DLA; Robert A; Noubiap JJ
Biomark Res; 2020; 8():37. PubMed ID: 32879731
[TBL] [Abstract][Full Text] [Related]
2. Comparison of laboratory parameters in mild
Cao B; Jing X; Liu Y; Wen R; Wang C
J Thorac Dis; 2022 May; 14(5):1478-1487. PubMed ID: 35693606
[TBL] [Abstract][Full Text] [Related]
3. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review.
Li X; Pan X; Li Y; An N; Xing Y; Yang F; Tian L; Sun J; Gao Y; Shang H; Xing Y
Crit Care; 2020 Jul; 24(1):468. PubMed ID: 32723362
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Zhu Z; Wang M; Lin W; Cai Q; Zhang L; Chen D; Liu F; Xiong X; Chu J; Peng J; Chen K
Immun Inflamm Dis; 2021 Dec; 9(4):1071-1100. PubMed ID: 34405950
[TBL] [Abstract][Full Text] [Related]
6. Serum CK-MB, COVID-19 severity and mortality: An updated systematic review and meta-analysis with meta-regression.
Zinellu A; Sotgia S; Fois AG; Mangoni AA
Adv Med Sci; 2021 Sep; 66(2):304-314. PubMed ID: 34256241
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.
Huang I; Pranata R; Lim MA; Oehadian A; Alisjahbana B
Ther Adv Respir Dis; 2020; 14():1753466620937175. PubMed ID: 32615866
[TBL] [Abstract][Full Text] [Related]
8. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
[TBL] [Abstract][Full Text] [Related]
9. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis.
Soraya GV; Ulhaq ZS
Med Clin (Barc); 2020 Aug; 155(4):143-151. PubMed ID: 32586670
[TBL] [Abstract][Full Text] [Related]
10. Cardiac biomarkers and COVID-19: A systematic review and meta-analysis.
An W; Kang JS; Wang Q; Kim TE
J Infect Public Health; 2021 Sep; 14(9):1191-1197. PubMed ID: 34416596
[TBL] [Abstract][Full Text] [Related]
11. CRP, SAA, LDH, and DD predict poor prognosis of coronavirus disease (COVID-19): a meta-analysis from 7739 patients.
Wang L; Yang LM; Pei SF; Chong YZ; Guo Y; Gao XL; Tang QY; Li Y; Feng FM
Scand J Clin Lab Invest; 2021 Dec; 81(8):679-686. PubMed ID: 34762008
[TBL] [Abstract][Full Text] [Related]
12. Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital.
Punzalan FER; Aherrera JAM; de Paz-Silava SLM; Mondragon AV; Malundo AFG; Tan JJE; Tantengco OAG; Quebral EPB; Uy MNAR; Lintao RCV; Dela Rosa JGL; Mercado MEP; Avenilla KC; Poblete JB; Albay AB; David-Wang AS; Alejandria MM
Front Immunol; 2023; 14():1123497. PubMed ID: 36926338
[TBL] [Abstract][Full Text] [Related]
13. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis.
Soraya GV; Ulhaq ZS
Med Clin (Engl Ed); 2020 Aug; 155(4):143-151. PubMed ID: 32864456
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis.
Hariyanto TI; Japar KV; Kwenandar F; Damay V; Siregar JI; Lugito NPH; Tjiang MM; Kurniawan A
Am J Emerg Med; 2021 Mar; 41():110-119. PubMed ID: 33418211
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.
Elshazli RM; Toraih EA; Elgaml A; El-Mowafy M; El-Mesery M; Amin MN; Hussein MH; Killackey MT; Fawzy MS; Kandil E
PLoS One; 2020; 15(8):e0238160. PubMed ID: 32822430
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
[TBL] [Abstract][Full Text] [Related]
17. Hemostatic Changes in Patients with COVID-19: A Meta-Analysis with Meta-Regressions.
Di Minno MND; Calcaterra I; Lupoli R; Storino A; Spedicato GA; Maniscalco M; Di Minno A; Ambrosino P
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32679766
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of severe cases with COVID-19: a meta-analysis.
Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
[TBL] [Abstract][Full Text] [Related]
19. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
[TBL] [Abstract][Full Text] [Related]
20. Assessing the Elevation of Cardiac Biomarkers and the Severity of COVID-19 Infection: A Meta-analysis.
Walker C; Deb S; Ling H; Wang Z
J Pharm Pharm Sci; 2020; 23():396-405. PubMed ID: 33086028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
